TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29031573

Group type: EXPERIMENTAL
Intervention: Aerosolized furosemide (40mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 25968162

Group type: EXPERIMENTAL
Intervention: 980-nm diode laser with the power of 6-8 W
Number of subjects: 36

Group type: COMPARATOR
Intervention: Traditional liposuction
Number of subjects: 36
Study: 23962491

Group type: EXPERIMENTAL
Intervention: 'Let Us Protect Our Future!' HIV/STD risk-reduction intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 0
Study: 22751690

Group type: EXPERIMENTAL
Intervention: Breakfast
Number of subjects: 20
Study: 20185637

Group type: EXPERIMENTAL
Intervention: Oral tolvaptan
Number of subjects: 111
Study: 17646058

Group type: EXPERIMENTAL
Intervention: Computer‐assisted tailored telephone counseling
Number of subjects: 2817

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 2817
Study: 16322336

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) treatment
Number of subjects: 88
Study: 12077544

Group type: EXPERIMENTAL
Intervention: 2% ketoconazole + 0.05% desonide gel (n = 9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Unmedicated gel (placebo) (n = 9)
Number of subjects: 18
Study: 9534557

Group type: EXPERIMENTAL
Intervention: Granuflex dressing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spenco Dermal dressing
Number of subjects: 0
Study: 8541695

Group type: EXPERIMENTAL
Intervention: Structured-triglyceride (STG) emulsion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Long-chain fatty acid triglyceride (LCT; Intralipid 20%) emulsion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Structured-triglyceride (STG) emulsion (medium and high doses)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fat infusion (STG and LCT)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All groups receiving STG and LCT emulsions
Number of subjects: 8
Study: 1708118

Group type: EXPERIMENTAL
Intervention: Low power laser stimulation (904 nm infrared diode laser)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 434583

Group type: EXPERIMENTAL
Intervention: Oral terbutaline (5 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Simultaneous ingestion of terbutaline and Tedral
Number of subjects: 14

Group type: COMPARATOR
Intervention: Tedral
Number of subjects: 14
Study: 31812554

Group type: EXPERIMENTAL
Intervention: Pembrolizumab at an initial dose of 2 mg/kg every 3 weeks
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Pembrolizumab in patients with solid tumours and other lymphomas
Number of subjects: 155
Study: 31144672

Group type: EXPERIMENTAL
Intervention: Pain Guard app
Number of subjects: 58
Study: 28439186

Group type: EXPERIMENTAL
Intervention: Reduction in diabetes-related distress (n=79)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Worsening or unchanged diabetes distress (n=50)
Number of subjects: 129
Study: 25845768

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 547

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 547
Study: 23379590

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (1500 mg-3000 mg)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate
Number of subjects: 258
Study: 21113641

Group type: EXPERIMENTAL
Intervention: rTSMS (10 Hz, 100% intensity of stimulator output, n=14)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham stimulation (n=13)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: rTSMS
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study: 19175617

Group type: EXPERIMENTAL
Intervention: High permeability haemodialysis (HPHD)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Conventional haemodialysis (CHD)
Number of subjects: 116
Study: 18036080

Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg) administered every 2 hours each night for 4 administrations
Number of subjects: 23

Group type: COMPARATOR
Intervention: No caffeine (control group)
Number of subjects: 23
Study: 15169748

Group type: EXPERIMENTAL
Intervention: Surprise hard surface (411 kN/m)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expected hard surface (411 kN/m)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random hard surface (411 kN/m)
Number of subjects: 0
Study: 11320608

Group type: EXPERIMENTAL
Intervention: Standardized hemicraniectomy and duraplasty
Number of subjects: 92

Group type: COMPARATOR
Intervention: Traditional craniotomy (with brain amputation at the neurosurgeon's discretion)
Number of subjects: 92
Study: 9462190

Group type: EXPERIMENTAL
Intervention: Volume controlled ventilation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Time cycled, pressure limited ventilation
Number of subjects: 50
Study: 8203435

Group type: EXPERIMENTAL
Intervention: Preoperative gonadotropin-releasing hormone agonist (leuprolide acetate) for 2 months
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Preoperative gonadotropin-releasing hormone agonist (leuprolide acetate)
Number of subjects: 150
Study: 3115283

Group type: EXPERIMENTAL
Intervention: alfentanil
Number of subjects: 44

Group type: COMPARATOR
Intervention: halothane
Number of subjects: 44
Study: 31944420

Group type: EXPERIMENTAL
Intervention: Zirconia implants
Number of subjects: 22

Group type: COMPARATOR
Intervention: Titanium implants
Number of subjects: 22
Study: 29203473

Group type: EXPERIMENTAL
Intervention: THR‐184 treatment groups
Number of subjects: 452

Group type: COMPARATOR
Intervention: Placebo groups
Number of subjects: 452
Study: 28824757

Group type: EXPERIMENTAL
Intervention: WOOP
Number of subjects: 34

Group type: COMPARATOR
Intervention: Goal Setting
Number of subjects: 34
Study: 25760511

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic fields
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 66
Study: 22966852

Group type: EXPERIMENTAL
Intervention: Long LVLED (LVLED ≥ 50% of QRS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Short LVLED (LVLED < 50%)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Long LVLED
Number of subjects: 31

Group type: COMPARATOR
Intervention: Short LVLED
Number of subjects: 31
Study: 20556561

Group type: EXPERIMENTAL
Intervention: Eprosartan 600 mg + Hydrochlorothiazide 12.5 mg
Number of subjects: 155

Group type: COMPARATOR
Intervention: Losartan 50 mg + Hydrochlorothiazide 12.5 mg
Number of subjects: 155
Study: 18277347

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound (TV ultrasound) using the Toshiba JustVision 400 system at the end of the surgical procedure.
Number of subjects: 720

Group type: COMPARATOR
Intervention: Control group (no ultrasound examination at the end of surgery).
Number of subjects: 720
Study: 15842137

Group type: EXPERIMENTAL
Intervention: Jianpi Huoxue herbs (JPHXH) plus chemotherapy (CT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Chemotherapy (CT) alone
Number of subjects: 64
Study: 12740051

Group type: EXPERIMENTAL
Intervention: Dietary fibre intake
Number of subjects: 4080
Study: 10229292

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 3250

Group type: EXPERIMENTAL
Intervention: Single drug therapy (most commonly an ACE inhibitor)
Number of subjects: 3250
Study: 8708070

Group type: EXPERIMENTAL
Intervention: Contrast medium injected over 30 s (Group A)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Contrast medium injected over 45 s (Group B)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Contrast medium injected over 60 s (Group C)
Number of subjects: 119
Study: 1751272

Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg kg‐1 followed by fentanyl 2 micrograms kg‐1
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 12
Study: 6936524

Group type: EXPERIMENTAL
Intervention: Hydrocodone-acetaminophen combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Codeine-acetaminophen combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Codeine-APC combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31583824

Group type: EXPERIMENTAL
Intervention: Cognitive restructuring intervention 'Michael's game'
Number of subjects: 172

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 172
Study: 31150729

Group type: EXPERIMENTAL
Intervention: 3.14% potassium oxalate strip
Number of subjects: 80

Group type: COMPARATOR
Intervention: 8% arginine calcium carbonate toothpaste (control)
Number of subjects: 80
Study: 28024265

Group type: EXPERIMENTAL
Intervention: Experimental supportive care approach (psychosocial nurse referral to healthcare providers)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Experimental supportive care approach
Number of subjects: 223
Study: 25913937

Group type: EXPERIMENTAL
Intervention: 1MIN‐HIIT
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 2MIN‐HIIT
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 25
Study: 23357431

Group type: EXPERIMENTAL
Intervention: High-energy variant of soup (HE spinach)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-energy variant of soup (LE endive)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vegetable soup consistently paired with high energy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vegetable soup consistently paired with low energy
Number of subjects: 40
Study: 21377930

Group type: EXPERIMENTAL
Intervention: Zalutumumab plus best supportive care
Number of subjects: 286

Group type: COMPARATOR
Intervention: Best supportive care (control group)
Number of subjects: 286
Study: 19541918

Group type: COMPARATOR
Intervention: Individualized best conventional therapy (CONV)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Standardized impairment-oriented training (IOT)
Number of subjects: 148
Study: 17578986

Group type: EXPERIMENTAL
Intervention: Bilateral glossopharyngeal nerve block with 0.75% ropivacaine with epinephrine (Group R)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Bilateral glossopharyngeal nerve block with 0.5% bupivacaine with epinephrine (Group B)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No intervention (Group C)
Number of subjects: 75
Study: 14988688

Group type: EXPERIMENTAL
Intervention: Potent, selective inhibitor of type I 5 alpha-reductase used alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potent, selective inhibitor of type I 5 alpha-reductase in combination with systemic minocycline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11377310

Group type: COMPARATOR
Intervention: Room temperature irrigation fluid (70 degrees F)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Warmed irrigation fluid (91.5 degrees F)
Number of subjects: 56
Study: 10211015

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with bupivacaine (40 mg bolus followed by 15 mg h‐1 infusion)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no epidural analgesia)
Number of subjects: 20
Study: 8155447

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nitroglycerin (NTG)
Number of subjects: 16
Study: 2842146

Group type: EXPERIMENTAL
Intervention: Leguminous meal
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Mixed dietary fibre meal
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cereal meal
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: High-fibre test meals
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: All meals
Number of subjects: 25
Study: 29861139

Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 1713

Group type: EXPERIMENTAL
Intervention: Endarterectomy
Number of subjects: 1713

Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 1713
Study: 28243467

Group type: EXPERIMENTAL
Intervention: Strontium ranelate (not detailed in the abstract)
Number of subjects: 869

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 869
Study: 26571884

Group type: EXPERIMENTAL
Intervention: Acupuncture and medication group (acupuncture + 20 mg fluoxetine once daily for 4 weeks)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Medication group (20 mg fluoxetine once daily for 4 weeks)
Number of subjects: 63
Study: 23045995

Group type: EXPERIMENTAL
Intervention: Telephone-delivered health education (THE)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Telephone-delivered interpersonal counselling (TIP-C)
Number of subjects: 71
Study: 21037250

Group type: EXPERIMENTAL
Intervention: Recurrent myocardial infarction (MI)
Number of subjects: 10599

Group type: EXPERIMENTAL
Intervention: Early reinfarctions (within 1 month)
Number of subjects: 10599
Study: 17851980

Group type: EXPERIMENTAL
Intervention: Increased mentally stimulating activities for 10-12 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 44
Study: 17146419

Group type: EXPERIMENTAL
Intervention: food supplement containing hydrolyzed sea fish cartilage, vitamin C, vitamin E, folic acid, zinc, copper (Captafer)
Number of subjects: 49

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: food supplement
Number of subjects: 49
Study: 14725385

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 2% zinc citrate and 0.3% Triclosan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Toothpaste containing 0.3% Triclosan and 2% copolymer
Number of subjects: 0
Study: 10811549

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 100 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 8604913

Group type: EXPERIMENTAL
Intervention: FOSL-HN (fish oil/medium-chain triglyceride structured lipid)
Number of subjects: 50

Group type: COMPARATOR
Intervention: O-HN (isonitrogenous, isocaloric formula)
Number of subjects: 50
Study: 1582107

Group type: COMPARATOR
Intervention: Conventional ibuprofen tablets 600 mg QID (CI)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Sustained-release ibuprofen tablets 1200 mg BID (SRI)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 147
Study: 3973309

Group type: EXPERIMENTAL
Intervention: Oral food challenge with suspected food
Number of subjects: 45

Group type: COMPARATOR
Intervention: History of allergic reactions
Number of subjects: 45

Group type: COMPARATOR
Intervention: Reaction patterns reported by history
Number of subjects: 45

Group type: COMPARATOR
Intervention: Complete blood count with differential, blood chemistries, and serum immunoglobulin levels
Number of subjects: 45
Study: 31481571

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 200
Study: 27369044

Group type: EXPERIMENTAL
Intervention: Bi-weekly emails for first 4 weeks and then weekly emails for the next 8 weeks targeting self‐efficacy, social support, goal setting, and benefits/barriers to walking (Dog owners)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Bi-weekly emails for first 4 weeks and then weekly emails for the next 8 weeks targeting self‐efficacy, social support, goal setting, and benefits/barriers to walking (Non-dog owners)
Number of subjects: 105

Group type: COMPARATOR
Intervention: 1-time email reviewing current physical activity guidelines (Control group)
Number of subjects: 105
Study: 26275164

Group type: EXPERIMENTAL
Intervention: Korean mindfulness-based stress reduction (K‐MBSR)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Patient education
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 56
Study: 23800154

Group type: EXPERIMENTAL
Intervention: Daily dietary supplementation with Creatine 340 mg + 320 mg Coenzyme Q‐Ter for 2 months (Group A)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (Group B)
Number of subjects: 55
Study: 21555764

Group type: EXPERIMENTAL
Intervention: Etravirine (ETR) 200 mg q12h
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etravirine (ETR) combined with Lopinavir (LPV)/Ritonavir (RTV) 200/400/100 mg q12h
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etravirine (ETR) combined with Darunavir (DRV)/Ritonavir (RTV) 200/600/100 mg q12h
Number of subjects: 0
Study: 19327739

Group type: EXPERIMENTAL
Intervention: Intraoperative sub-Tenon injection of triamcinolone acetonide (TA)
Number of subjects: 53

Group type: COMPARATOR
Intervention: No intraoperative sub-Tenon injection of triamcinolone acetonide (TA)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Both groups (TA and control)
Number of subjects: 53
Study: 17576909

Group type: COMPARATOR
Intervention: Steroids
Number of subjects: 20

Group type: COMPARATOR
Intervention: Antiviral plus steroid therapy
Number of subjects: 20
Study: 14718426

Group type: EXPERIMENTAL
Intervention: Formoterol
Number of subjects: 88

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 88
Study: 12053495

Group type: EXPERIMENTAL
Intervention: Triage angiography within 6 hours of symptom onset
Number of subjects: 201

Group type: COMPARATOR
Intervention: Conventional medical care
Number of subjects: 201
Study: 9556926

Group type: EXPERIMENTAL
Intervention: Detection of antibodies against Trypanosoma cruzi using a commercial ELISA kit
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Repeated blood donation
Number of subjects: 318
Study: 8052870

Group type: EXPERIMENTAL
Intervention: Carboplatin/etoposide chemotherapy and thoracic irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cisplatin/etoposide chemotherapy and thoracic irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thoracic irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic brain irradiation
Number of subjects: 0
Study: 3396492

Group type: EXPERIMENTAL
Intervention: Cefoxitin 2g
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cefotaxime 2g
Number of subjects: 40
Study: 31177755

Group type: EXPERIMENTAL
Intervention: Aluminium content in wheat
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Aluminium content in soybean
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Aluminium content in corn
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Aluminium content in rice
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Aluminium content in millet
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Upper bound values of 95%CI of P(99) of aluminium contents
Number of subjects: 454
Study: 28870191

Group type: EXPERIMENTAL
Intervention: Translatory dorsal glide mobilization (TDGM) C0‐C1 technique, adjunct to protocolized physiotherapy treatment
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Pressure maintained suboccipital inhibition technique (PMSIT), adjunct to protocolized physiotherapy treatment
Number of subjects: 78

Group type: COMPARATOR
Intervention: Protocolized treatment (Control Group)
Number of subjects: 78
Study: 26004142

Group type: COMPARATOR
Intervention: CCBT
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: CCBT + MCBT
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: CCBT + MCI
Number of subjects: 211
Study: 22978325

Group type: EXPERIMENTAL
Intervention: Music-movement therapy (60 minutes, three times per week for 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 0
Study: 22101378

Group type: EXPERIMENTAL
Intervention: Oral valganciclovir (VGCV) 900 mg/day
Number of subjects: 22

Group type: COMPARATOR
Intervention: Intravenous ganciclovir (GCV) 5 mg/kg twice daily
Number of subjects: 22
Study: 18207117

Group type: EXPERIMENTAL
Intervention: Speeded detection task with audiovisual displays
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Speeded modality discrimination task with audiovisual displays
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Constant task with visual targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Constant task with auditory targets
Number of subjects: 0
Study: 16436892

Group type: EXPERIMENTAL
Intervention: Paired hemodiafiltration (PHF)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard dialysis (bicarbonate dialysis)
Number of subjects: 12
Study: 14604204

Group type: EXPERIMENTAL
Intervention: Flush before fill
Number of subjects: 121

Group type: COMPARATOR
Intervention: No flush
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Flush before fill (females)
Number of subjects: 121

Group type: COMPARATOR
Intervention: No flush (females)
Number of subjects: 121
Study: 10790839

Group type: EXPERIMENTAL
Intervention: Asthma education space adventure game (Air Academy: The Quest for Airtopia)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control classroom (no computer game)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physician-led talks (additional intervention)
Number of subjects: 0
Study: 9392919

Group type: EXPERIMENTAL
Intervention: Exam A
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Exam B
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Combined Exams A and B
Number of subjects: 78

Group type: COMPARATOR
Intervention: Urinary catheterization
Number of subjects: 78
Study: 8131458

Group type: COMPARATOR
Intervention: Conventional ventilation (TI=25 percent, pause=10 percent)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inspiratory flow rate (TI=20 percent) without end-inspiratory pause
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inspiratory flow rate (TI=33 percent) without end-inspiratory pause
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inspiratory flow rate (TI=50 percent) without end-inspiratory pause
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inspiratory flow rate (TI=67 percent) without end-inspiratory pause
Number of subjects: 11
Study: 2941056

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg/Codeine 30 mg (medium-dose combination)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: High dose ibuprofen/codeine combination
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Low dose ibuprofen/codeine combination
Number of subjects: 165
Study: 31556212

Group type: EXPERIMENTAL
Intervention: Chronic Pain Self-Management Program (CPSMP)
Number of subjects: 394